Truly global solutions required, says WHO Director-General Media release 23 January 2013 Pages: 2 - 2
The UK NICE has recently issued final guidance recommending the use of sunitinib Media release 23 January 2013 Pages: 2 - 2
The UK NICE has issued new guidance on the management of schizophrenia Media release 23 January 2013 Pages: 2 - 2
Positive perceptions about generics, generally, in the US Non-clinical study 23 January 2013 Pages: 3 - 3
The new American Recovery and Reinvestment Act (ARRA) will dramatically increase the adoption of e-prescribing Media release 23 January 2013 Pages: 3 - 3
Millennium Development Goals may not be met, warns Working Group Media release 23 January 2013 Pages: 3 - 3
“Vaccination of high-risk infants and family and household contacts of [hepatitis B] positive mothers in London is suboptimal” Clinical study 23 January 2013 Pages: 4 - 4
Pegfilgrastim prophylaxis cost effective in early breast cancer Clinical study 23 January 2013 Pages: 4 - 4
According to a study conducted in Belgium, parents of infants and adolescents Clinical study 23 January 2013 Pages: 5 - 5
Amlodipine-based therapy + atorvastatin wins in hypertension Clinical study 23 January 2013 Pages: 5 - 5
Emtricitabine/tenofovir prophylaxis appears “unattractive” in US Clinical study 23 January 2013 Pages: 6 - 6
Rehospitalisations for US Medicare patients are frequent, costly News item 23 January 2013 Pages: 7 - 7
The economic burden of knee and hip osteoarthritis (OA) in Spain is “substantial” Clinical study 23 January 2013 Pages: 7 - 7
Productivity loss due to refractive errors a real eye opener Clinical study 23 January 2013 Pages: 9 - 9
A poll by Consumer Reports has shown that the majority of Americans appear to be unaware of the cost of their prescriptions until the script is filled Media release 23 January 2013 Pages: 9 - 9
A revolving drug fund (RDF) has been successfully established in the Khartoum state of the Sudan Clinical study 23 January 2013 Pages: 10 - 10
Subclinical hypothyroidism worth screening for in pregnancy Clinical study 23 January 2013 Pages: 10 - 10
Australia's nationally funded Q fever vaccination programme has improved vaccination coverage leading to a reduction in disease incidence Epidemiology clinical study 23 January 2013 Pages: 11 - 11
Patients of a lower socioeconomic status are more likely to regularly use proton pump inhibitors Epidemiology clinical study 23 January 2013 Pages: 11 - 11
Value of statins for primary prevention of CVD questioned Clinical study 23 January 2013 Pages: 11 - 11
A quality quota of QALY with quetiapine XR for schizophrenia Clinical study 23 January 2013 Pages: 12 - 12
Home therapy with intravenous complement C1 inhibitor protein improves QOL Clinical study 23 January 2013 Pages: 13 - 13
Research into oral TB therapies to get £18 million boost Media release 23 January 2013 Pages: 13 - 13
The potential impact of rotavirus vaccines could save more than 2.5 million lives by 2025 Media release 23 January 2013 Pages: 13 - 13
Wyeth's pneumococcal 7-valent CRM197 conjugate vaccine [Prevenar] has been added to Saudi Arabia's national immunisation programme Media release 23 January 2013 Pages: 14 - 14
A coalition of AIDS activists in Mexico have claimed victory over Abbott Laboratories regarding the company's pricing of lopinavir/ritonavir [Kaletra] Media release 23 January 2013 Pages: 14 - 14
An additional funded treatment will be available for hepatitis B patients in New Zealand Media release 23 January 2013 Pages: 14 - 14
The US back pain market will be valued at almost $23 billion in 2018, with growth driven largely by opioid receptor agonist products Media release 23 January 2013 Pages: 15 - 15
The small cell lung cancer (SCLC) drug market is predicted to double by 2017, despite “disappointing” drug development in this area Media release 23 January 2013 Pages: 15 - 15
For the first time in history, generic drugs now account for the majority of all prescriptions in Canada Media release 23 January 2013 Pages: 15 - 15